For Third Consecutive Year, 10 Students with Gastrointestinal Disease Will Each Receive a $10,000 Scholarship LAVAL, QC, July 13, 2022 — Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”) and …
Topic:
salix
-
-
Salix to Share New Data from XIFAXAN® (Rifaximin) Clinical Research at EASL’s International Liver Congress™ 2022
by Your NewsLAVAL, QC, June 20, 2022 — Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”) and its gastroenterology business, Salix Pharmaceuticals, (“Salix”), one of the largest specialty pharmaceutical companies in the …
-
XIFAXAN® (rifaximin), TRULANCE® (plecanatide) and PLENVU® Research Posters Will Be Presented LAVAL, Quebec, May 18, 2022 — Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”) and its gastroenterology business, Salix …
-
GrubMarket acquires Salix Fruits, a global fresh fruit provider with operations in Argentina, Chile, Brazil, South Africa, New Zealand, Spain, India, the U.S., and other regions, to expand into South …
-
SALIX PHARMACEUTICALS WILL PRESENT SCIENTIFIC DATA AT THE SOCIETY OF HOSPITAL MEDICINE CONVERGE 2022
by Your NewsFeatured Posters Will Include XIFAXAN® (rifaximin) and RELISTOR® (methylnaltrexone bromide) Research BRIDGEWATER, N.J., April 7, 2022 — Salix Pharmaceuticals (“Salix”), the gastroenterology business of Bausch Health Companies Inc. (NYSE/TSX: BHC) …